Atlas Trials

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Clinical trial NCT06562543 · RECRUITING

Trial details

NCT number
NCT06562543
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2025-01-14
Primary completion
2027-10-04
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.